Full-face Rejuvenation Research Articles

A faster CO2 fractional scanner system mode for skin rejuvenation. A clinical study.

The market requires ever-faster techniques, in particular for pre-rejuvenation condition. The purpose of this study was to assess if a fractional CO2 scanner modality (called moveo) results in a faster full-face rejuvenation treatment in comparison to the standard mode, currently existing in the scanner system. A total of 12 female patients affected by fine lines participated in a split-face clinical investigation and underwent to two sessions with a fractional CO2 laser system equipped with an existing and a faster dedicated scanner units. Pain was assessed using VAS. Three-dimensional clinical photographs were captured before, immediately after, 3 days, 14 days after the first treatment and immediately after the second treatment and 1 months after the last one. The uniformity and aesthetic coverage of treatments were assessed using dermatoscopy. Global aesthetic improvement scale (GAIS) was used. The time taken to treat the two sides of the face and all possible side effects were monitored. Following only two treatment session with both scanner modes, the patient's skin texture improved significantly, with fine lines reduction. There is no statistically significant difference in perceived pain between patients. The GAIS score showed satisfactory results following both modalities. The time parameters indicated that with the faster scanner mode the full-face treatment time was reduced by 30% compared to the standard one. No adverse effects were observed. The moveo modality provide faster treatment and a better final dermal aesthetic outcome than the standard procedure while maintaining the same safety profile.

Non surgical facial reshaping using MD Codes.

Both age-related and congenital volume deficiencies may be addressed through the injection of hyaluronic acid (HA) fillers. Deep injection provides structural support, more superficial fat-tissue injection mediates contouring, and superficial intradermal use of HA filler and/or onabotulinumtoxinA may be used for refinement. To evaluate the clinical efficacy, patient satisfaction, and safety of the MD Codes approach as a proposed standardized methodology for full-face rejuvenation. This was a retrospective, single-center study of 250 consecutive adult patients undergoing full-face rejuvenation with HA fillers (Vycross) and onabotulinumtoxinA based on the MD Codes approach. The mean age was 39.4±11.6years, and 80.4% were female. All patients were treated with HA filler in the midface; 89.6% were also treated in the upper face, and 63.2% in the lower face. The mean number of syringes used was 14±4 (range 4-25), with more syringes typically required in older versus younger patients. All patients received onabotulinumtoxinA treatment. Mean FACE-Q Appearance-Related Psychosocial Distress score decreased from 54.3±9.3 pretreatment to 36.1±8.9 at 3months post-treatment (P<.05). The most common complications were bruising (35.2%), transient soft-tissue edema (14.0%), and prolonged periorbital edema (3.6%). Full-face rejuvenation based on the MD Codes approach provides significant esthetic improvements, with no major safety issues observed.

Full-Face Rejuvenation with Hyaluronic Acid Fillers based on the MD Codes Technique: A Retrospective, Single-Center Study

Background: Increased standardization may be necessary to maximize benefits and minimize complications with fullface rejuvenation using hyaluronic acid (HA) fillers. The aim of this study was to assess the utility and safety of the standardized MD Codes approach. Methods: This was a retrospective review of data from 84 patients receiving full-face rejuvenation with HA fillers using the MD Codes technique within a single treatment plan, across two visits separated by ~1 month. Results: Participants had a mean age of 49.1 ± 9.9 years, and 83 (98.8%) were female. They were treated with 527 syringes of filler (6.3 ± 1.8 per patient): 334 syringes (63.4%; 4.0 ± 1.5 per patient) during visit 1 and 193 (36.6%; 2.3 ± 1.1 per patient) during visit 2. The most commonly treated areas were the cheek (n=84; 100%) and nasolabial fold (n=26; 31.0%) at visit 1, and the nasolabial fold (n=36; 43.9%) and tear trough (n=35; 42.7%) at visit 2. Eight adverse events were recorded in 6 patients (7.1%): bruising, n=4; pain, n=4. All were minor and transient. There were no lateonset complications. Conclusion: Full-face rejuvenation using the MD Codes technique can be successfully performed with minimal complications. This approach may define a new standard of care.

The Masseter Muscle and Its Role in Facial Contouring, Aging, and Quality of Life: A Literature Review.

Masseter muscle hypertrophy manifests itself as enlargement of the masseter muscle. It can be associated with a square-angled lower face, pain, dental attrition, maxillary and mandibular bone resorption, and accelerated aging process of the lower face. The objective of this study was to assess the efficacy and safety of botulinum toxin type A in contouring the masseter and its impact on quality of life and the aging process of the lower face, and its role in full face rejuvenation. A PubMed search was conducted for articles on masseter treatment with botulinum toxin type A, masseter muscle hypertrophy, and the aging process of the lower face. Key studies are reviewed and findings are summarized. Botulinum toxin type A can be injected into the lower posterior aspect of the masseter muscle. Treatment decreases muscle bulk and reshapes the lower face. Furthermore, patient quality-of-life measures, including pain and symptoms of grinding and clenching, are improved. Treatment can decrease shear stress on maxillary and mandibular bones and can possibly prevent tooth loss and progressive bone resorption of the lower face. Adverse effects are minimal and short lasting. Botulinum toxin type A is a safe and effective treatment of masseter hypertrophy. The treatment results in improvement of functionality and cosmesis, and restoration of facial harmony.

Role of Nonsurgical Chin Augmentation in Full Face Rejuvenation: A Review and Our Experience.

The chin is a critical component to the perception of facial attractiveness. Dermal fillers offer a nonsurgical, temporary method of correcting mild to moderate chin retrusion and resorption. Thus far, discussion of this procedure has been largely limited to the plastic surgery and otolaryngology literature. To review pertinent aspects of anatomy, patient evaluation, injection technique, concomitant therapies, and complications in chin augmentation using injectable fillers. A brief review of the literature surrounding chin augmentation using injectable fillers, as well as the authors' experience in this area, is provided. Chin augmentation using injectable fillers can be performed effectively and safely with adequate background knowledge of the regional anatomy and appropriate patient selection. The authors discuss both injection techniques in the published literature and their own approach. Potential complications and concomitant therapies are also reviewed. As chin augmentation is increasingly recognized as an essential component to complete facial aesthetic rejuvenation, dermatologic surgeons should be familiar with how to safely and effectively perform augmentation with injectable fillers to achieve an optimal cosmetic outcome.

Full-Face Rejuvenation Using a Range of Hyaluronic Acid Fillers: Efficacy, Safety, and Patient Satisfaction over 6 Months

Full-face rejuvenation with dermal fillers in patients with multiple aesthetic indications is rarely studied. To assess whether a new range of hyaluronic acid filler is suitable for full-face rejuvenation and to evaluate efficacy, safety, and patient satisfaction. In this 6-month study, participants could receive five different fillers from the same range (HA(E) )for up to eight indications (periorbital lines, tear troughs, cheeks, cheek folds, nasolabial folds, upper lip lines, lips, and marionette lines). Outcomes included global aesthetic improvement, improvement in each indication, adverse events, local tolerability, and satisfaction. Seventy-seven participants with a mean age of 54.5 were enrolled; 48.1% had five or more indications treated. Mean total injection volume (baseline and touch-up) per participant was 6.7 mL. At month 6, 92.1% of participants remained at least improved over baseline, 79.7% of participants were satisfied or very satisfied with the durability of the results, and 63.0% of participants felt a lot or much better than before injection. No specific safety concerns were reported except expected injection site reactions. In participants with multiple indications, full-face rejuvenation using HA(E) provided effective, safe, satisfactory results.

Midface Fat Augmentation Is Linchpin of Full-Face Rejuvenation

Midface Fat Augmentation Is Linchpin of Full-Face Rejuvenation

Circumauricular Incision (Water-Drop Shape) for Mid- to Lower Face Lift

The conventional method of mid- to lower face rhytidectomy that involves removing a strip of occipital scalp always creates a conspicuous transverse scar crossing the postauricular skin, which may leave a stair-step deformity at the occipital hairline. The author has designed a new face lift method using a circumauricular incision, shaped like a water droplet, that curves around the auricle. In this new method, the upper part of the "O" shape is modified to the tip of a water droplet. The dissection of the cheek and neck is performed as in the conventional method with light-retractor assistance. The temporal region above the deep temporal fascia is managed under endoscopic control. This dissection can extend to the forehead region lateral to the supraoptic nerve and around the lateral orbital rim to release the arcus marginalis. A mesentery of superficial temporal fascia is created cephalic to the zygomatic arch. The postauricular dissection is performed beneath the galea in the upper part and beneath the occipital scalp and neck skin in the lower area. The lifting vector is upward and backward for the anterior skin flap and upward for the posterior skin flap. The excess skin is trimmed around the ear. The wound at the upper pole of the incision is closed in a V-to-Y advancement fashion. The dog-ear is left above the normal hairline, and there is little or no hairy scalp to be removed. The skin pleating in the postauricular region will settle down spontaneously after several months. The dog-ear in the scalp will become smaller and flat as well. The scar around the ear is quite inconspicuous and well covered under the upper pole of the auricle. From the author's experience, the new "water drop" circumauricular incision is a good alternative for the mid- to lower face lift. It can also be used in conjunction with endoforehead lift for full-face rejuvenation.

Application of three-dimensional concept in full face rejuvenation

目的 探索在面部除皱术中应用三维概念恢复年轻时的面部轮廓形态.方法全身麻醉下进行全面部除皱术,术中应用了面颊部软组织折叠,面部局部吸脂,移动或复位下移的面部脂肪袋、脂肪移植及组织代用品置入等手术方法.结果从2001年2月至2004年5月,完成手术18例,达到良好的除皱效果.结论通过以上手术方法,使面部除皱术中三维概念得到体现,不仅获得良好的除皱效果而且面部轮廓形态也得到明显改善。